Mark Jonas

461 total citations
10 papers, 208 citations indexed

About

Mark Jonas is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mark Jonas has authored 10 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Mark Jonas's work include Liver Disease and Transplantation (3 papers), Hepatitis C virus research (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Mark Jonas is often cited by papers focused on Liver Disease and Transplantation (3 papers), Hepatitis C virus research (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Mark Jonas collaborates with scholars based in United States, United Kingdom and Taiwan. Mark Jonas's co-authors include Guy Neff, Nyingi Kemmer, David M. Novick, Ravi Ravinuthala, Michael Jones, Tiffany E. Kaiser, Elysse M. Craddock, Joseph G. Gall, Joseph F. Buell and Petr Husa and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Mark Jonas

10 papers receiving 202 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Jonas United States	6	140	137	65	28	17	10	208
Hiroshi Kamitsukasa Japan	9	209 1.5×	206 1.5×	17 0.3×	20 0.7×	46 2.7×	18	298
Louis Leblanc France	7	110 0.8×	82 0.6×	41 0.6×	31 1.1×	7 0.4×	11	197
Angelo Deplano Italy	6	150 1.1×	174 1.3×	7 0.1×	32 1.1×	8 0.5×	7	321
M. Lagget Italy	14	424 3.0×	381 2.8×	50 0.8×	11 0.4×	51 3.0×	27	516
Arianna Biffi Italy	10	85 0.6×	48 0.4×	36 0.6×	19 0.7×	47 2.8×	21	263
Michiyasu Yagura Japan	9	164 1.2×	165 1.2×	31 0.5×	22 0.8×	47 2.8×	22	276
Shifang Peng China	7	113 0.8×	104 0.8×	40 0.6×	53 1.9×	15 0.9×	17	241
Satoshi Shirahama Japan	10	79 0.6×	51 0.4×	23 0.4×	33 1.2×	6 0.4×	24	316
Fatih Karakaya Türkiye	9	331 2.4×	288 2.1×	51 0.8×	75 2.7×	34 2.0×	26	411
Louise B. Thingholm Germany	7	51 0.4×	49 0.4×	38 0.6×	85 3.0×	23 1.4×	12	163

Countries citing papers authored by Mark Jonas

Since Specialization

Citations

This map shows the geographic impact of Mark Jonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jonas more than expected).

Fields of papers citing papers by Mark Jonas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Jonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jonas. The network helps show where Mark Jonas may publish in the future.

Co-authorship network of co-authors of Mark Jonas

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Jonas. A scholar is included among the top collaborators of Mark Jonas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Jonas. Mark Jonas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Jonas, Mark, et al.. (2019). Patterns of univariate and multivariate plasticity to elevated carbon dioxide in six European populations ofArabidopsis thaliana. Ecology and Evolution. 9(10). 5906–5915. 5 indexed citations

2.

Jonas, Mark, et al.. (2018). Induced mutations alter patterns of quantitative variation, phenotypic integration, and plasticity to elevated CO2 in Arabidopsis thaliana. Journal of Plant Research. 132(1). 33–47. 1 indexed citations

3.

Craddock, Elysse M., Joseph G. Gall, & Mark Jonas. (2016). Hawaiian Drosophila genomes: size variation and evolutionary expansions. Genetica. 144(1). 107–124. 16 indexed citations

4.

Neff, Guy, Michael Jones, Mark Jonas, et al.. (2013). Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 47(2). 188–192. 22 indexed citations

5.

Neff, Guy, Michael Jones, Taylor Broda, et al.. (2011). Durability of Rifaximin Response in Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 46(2). 168–171. 23 indexed citations

6.

McHutchison, John G., Zachary Goodman, Keyur Patel, et al.. (2009). Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection. Gastroenterology. 138(4). 1365–1373.e2. 66 indexed citations

7.

Atiq, Muslim, Kamran Safdar, F Weber, et al.. (2008). Adult Onset Urea Cycle Disorder in a Patient With Presumed Hepatic Encephalopathy. Journal of Clinical Gastroenterology. 42(2). 213–214. 17 indexed citations

8.

Neff, Guy, Nyingi Kemmer, Tiffany E. Kaiser, et al.. (2006). Analysis of Hospitalizations Comparing Rifaximin Versus Lactulose in the Management of Hepatic Encephalopathy. Transplantation Proceedings. 38(10). 3552–3555. 49 indexed citations

9.

Sokal, Étienne, Deanna L. Kelly, J. Mizerski, et al.. (2001). An international double-blind placebo-controlled trial of lamivudine in 286 children with chronic hepatitis B (CHB). Journal of Hepatology. 34. 23–23. 5 indexed citations

10.

Cunha, B. A., et al.. (1982). Tissue penetration characteristics of ceftizoxime and cefazolin in human bile and gallbladder wall. Journal of Antimicrobial Chemotherapy. 10(suppl C). 117–120. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact